Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleBasic Science Investigations

Preclinical Comparison of Al18F- and 68Ga-Labeled Gastrin-Releasing Peptide Receptor Antagonists for PET Imaging of Prostate Cancer

Kristell L.S. Chatalic, Gerben M. Franssen, Wytske M. van Weerden, William J. McBride, Peter Laverman, Erik de Blois, Bouchra Hajjaj, Luc Brunel, David M. Goldenberg, Jean-Alain Fehrentz, Jean Martinez, Otto C. Boerman and Marion de Jong
Journal of Nuclear Medicine December 2014, 55 (12) 2050-2056; DOI: https://doi.org/10.2967/jnumed.114.141143
Kristell L.S. Chatalic
1Department of Nuclear Medicine, Erasmus MC, Rotterdam, The Netherlands
2Department of Urology, Erasmus MC, Rotterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gerben M. Franssen
3Department of Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wytske M. van Weerden
2Department of Urology, Erasmus MC, Rotterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
William J. McBride
4Immunomedics, Inc., Morris Plains, New Jersey; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Laverman
3Department of Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Erik de Blois
1Department of Nuclear Medicine, Erasmus MC, Rotterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bouchra Hajjaj
5Institut des Biomolécules Max Mousseron, UMR 5247, CNRS-UM1-UM2, Montpellier, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Luc Brunel
5Institut des Biomolécules Max Mousseron, UMR 5247, CNRS-UM1-UM2, Montpellier, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David M. Goldenberg
4Immunomedics, Inc., Morris Plains, New Jersey; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jean-Alain Fehrentz
5Institut des Biomolécules Max Mousseron, UMR 5247, CNRS-UM1-UM2, Montpellier, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jean Martinez
5Institut des Biomolécules Max Mousseron, UMR 5247, CNRS-UM1-UM2, Montpellier, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Otto C. Boerman
3Department of Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marion de Jong
1Department of Nuclear Medicine, Erasmus MC, Rotterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 55 no. 12 2050-2056
DOI 
https://doi.org/10.2967/jnumed.114.141143
PubMed 
25413139

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication April 3, 2014
  • Accepted for publication September 5, 2014
  • Published online December 1, 2014.

Article Versions

  • previous version (November 20, 2014 - 05:44).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2014 by the Society of Nuclear Medicine and Molecular Imaging, Inc.

Author Information

  1. Kristell L.S. Chatalic1,2,
  2. Gerben M. Franssen3,
  3. Wytske M. van Weerden2,
  4. William J. McBride4,
  5. Peter Laverman3,
  6. Erik de Blois1,
  7. Bouchra Hajjaj5,
  8. Luc Brunel5,
  9. David M. Goldenberg4,
  10. Jean-Alain Fehrentz5,
  11. Jean Martinez5,
  12. Otto C. Boerman3 and
  13. Marion de Jong1
  1. 1Department of Nuclear Medicine, Erasmus MC, Rotterdam, The Netherlands
  2. 2Department of Urology, Erasmus MC, Rotterdam, The Netherlands
  3. 3Department of Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands
  4. 4Immunomedics, Inc., Morris Plains, New Jersey; and
  5. 5Institut des Biomolécules Max Mousseron, UMR 5247, CNRS-UM1-UM2, Montpellier, France
  1. For correspondence or reprints contact: Kristell L.S. Chatalic, Erasmus MC, Department of Nuclear Medicine, Na-620, Postbus 2040, 3000 CA Rotterdam, The Netherlands. E-mail: k.chatalic{at}erasmusmc.nl
View Full Text

Statistics from Altmetric.com

Cited By...

  • 50 Citations
  • 47 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • A Novel 111In-Labeled Anti–Prostate-Specific Membrane Antigen Nanobody for Targeted SPECT/CT Imaging of Prostate Cancer
    Kristell L.S. Chatalic, Joke Veldhoven-Zweistra, Michiel Bolkestein, Sander Hoeben, Gerben A. Koning, Otto C. Boerman, Marion de Jong, Wytske M. van Weerden
    Journal of Nuclear Medicine 2015 56 7
  • Bombesin related peptides/receptors and their promising therapeutic roles in cancer imaging, targeting and treatment
    Paola Moreno, Irene Ramos-Álvarez, Terry W. Moody, Robert T. Jensen
    Expert Opinion on Therapeutic Targets 2016 20 9
  • Prostate Cancer Theranostics Targeting Gastrin-Releasing Peptide Receptors
    Lucia Baratto, Hossein Jadvar, Andrei Iagaru
    Molecular Imaging and Biology 2018 20 4
  • A Comprehensive Review of Non-Covalent Radiofluorination Approaches Using Aluminum [18F]fluoride: Will [18F]AlF Replace 68Ga for Metal Chelate Labeling?
    Cyril Fersing, Ahlem Bouhlel, Christophe Cantelli, Philippe Garrigue, Vincent Lisowski, Benjamin Guillet
    Molecules 2019 24 16
  • PET Tracers Beyond FDG in Prostate Cancer
    David M. Schuster, Cristina Nanni, Stefano Fanti
    Seminars in Nuclear Medicine 2016 46 6
  • New Chelators for Low Temperature Al18F-Labeling of Biomolecules
    Frederik Cleeren, Joan Lecina, Emilie M. F. Billaud, Muneer Ahamed, Alfons Verbruggen, Guy M. Bormans
    Bioconjugate Chemistry 2016 27 3
  • 68Ga-NOTA-Aca-BBN(7–14) PET/CT in Healthy Volunteers and Glioma Patients
    Jingjing Zhang, Deling Li, Lixin Lang, Zhaohui Zhu, Ling Wang, Peilin Wu, Gang Niu, Fang Li, Xiaoyuan Chen
    Journal of Nuclear Medicine 2016 57 1
  • Direct fluorine-18 labeling of heat-sensitive biomolecules for positron emission tomography imaging using the Al18F-RESCA method
    Frederik Cleeren, Joan Lecina, Jessica Bridoux, Nick Devoogdt, Térence Tshibangu, Catarina Xavier, Guy Bormans
    Nature Protocols 2018 13 10
  • Exploring Structural Parameters for Pretargeting Radioligand Optimization
    Jan-Philip Meyer, Paul Kozlowski, James Jackson, Kristen M. Cunanan, Pierre Adumeau, Thomas R. Dilling, Brian M. Zeglis, Jason S. Lewis
    Journal of Medicinal Chemistry 2017 60 19
  • Radiopeptides for Imaging and Therapy: A Radiant Future
    Kristell L.S. Chatalic, Dik J. Kwekkeboom, Marion de Jong
    Journal of Nuclear Medicine 2015 56 12

Article usage

Article usage: November 2014 to April 2025

AbstractFullPdf
Nov 2014347078
Dec 20146203196
Jan 20152272643
Feb 20151182128
Mar 20151051724
Apr 20151001824
May 201575815
Jun 2015532919
Jul 2015592646
Aug 2015471929
Sep 2015792027
Oct 2015272227
Nov 2015352317
Dec 2015531615
Jan 2016603741
Feb 2016463232
Mar 2016211733
Apr 2016292343
May 2016301941
Jun 2016232327
Jul 2016221117
Aug 2016301619
Sep 2016262019
Oct 2016403432
Nov 2016563329
Dec 2016183020
Jan 2017344220
Feb 201720123
Mar 2017261822
Apr 201719109
May 2017192811
Jun 2017291514
Jul 201725911
Aug 2017231810
Sep 201723513
Oct 20172244
Nov 20171745
Dec 201710109
Jan 201815119
Feb 20181225
Mar 201814314
Apr 201811110
May 201815119
Jun 20181555
Jul 20181077
Aug 20181053
Sep 2018994
Oct 20187127
Nov 20181287
Dec 2018312
Jan 201919617
Feb 20195314
Mar 201918525
Apr 201991314
May 20191678
Jun 201981210
Jul 20197512
Aug 20198717
Sep 2019617
Oct 2019242314
Nov 20191286
Dec 201912512
Jan 20201176
Feb 20209810
Mar 20201148
Apr 2020201118
May 202071015
Jun 20201638
Jul 2020838
Aug 202011511
Sep 202013718
Oct 202019711
Nov 2020439
Dec 2020538
Jan 202151314
Feb 202192324
Mar 2021102215
Apr 2021488
May 2021101813
Jun 202181915
Jul 2021232325
Aug 202143216
Sep 20214612
Oct 202111623
Nov 20217823
Dec 202142712
Jan 202281810
Feb 20224189
Mar 202211313
Apr 202211211
May 202251413
Jun 20222169
Jul 202242113
Aug 202271410
Sep 202242311
Oct 202221911
Nov 20223168
Dec 2022293
Jan 202323420
Feb 20232186
Mar 202352510
Apr 202311710
May 202341414
Jun 20235117
Jul 202332117
Aug 202351615
Sep 202331615
Oct 202362415
Nov 202331212
Dec 202334511
Jan 2024104523
Feb 202433115
Mar 20246239
Apr 2024711812
May 202447610
Jun 202442513
Jul 202432416
Aug 202465425
Sep 202452912
Oct 202462015
Nov 2024124612
Dec 202465110
Jan 202521816
Feb 2025516512
Mar 202537722
Apr 202576129
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 55 (12)
Journal of Nuclear Medicine
Vol. 55, Issue 12
December 1, 2014
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Preclinical Comparison of Al18F- and 68Ga-Labeled Gastrin-Releasing Peptide Receptor Antagonists for PET Imaging of Prostate Cancer
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Preclinical Comparison of Al18F- and 68Ga-Labeled Gastrin-Releasing Peptide Receptor Antagonists for PET Imaging of Prostate Cancer
Kristell L.S. Chatalic, Gerben M. Franssen, Wytske M. van Weerden, William J. McBride, Peter Laverman, Erik de Blois, Bouchra Hajjaj, Luc Brunel, David M. Goldenberg, Jean-Alain Fehrentz, Jean Martinez, Otto C. Boerman, Marion de Jong
Journal of Nuclear Medicine Dec 2014, 55 (12) 2050-2056; DOI: 10.2967/jnumed.114.141143

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Preclinical Comparison of Al18F- and 68Ga-Labeled Gastrin-Releasing Peptide Receptor Antagonists for PET Imaging of Prostate Cancer
Kristell L.S. Chatalic, Gerben M. Franssen, Wytske M. van Weerden, William J. McBride, Peter Laverman, Erik de Blois, Bouchra Hajjaj, Luc Brunel, David M. Goldenberg, Jean-Alain Fehrentz, Jean Martinez, Otto C. Boerman, Marion de Jong
Journal of Nuclear Medicine Dec 2014, 55 (12) 2050-2056; DOI: 10.2967/jnumed.114.141143
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • Preclinical Investigation of [212Pb]Pb-DOTAM-GRPR1 for Peptide Receptor Radionuclide Therapy in a Prostate Tumor Model
  • 18F-AlF-Labeled Biomolecule Conjugates as Imaging Pharmaceuticals
  • Bombesin-Targeted PET of Prostate Cancer
  • 68Ga-NOTA-Aca-BBN(7-14) PET/CT in Healthy Volunteers and Glioma Patients
  • Radiopeptides for Imaging and Therapy: A Radiant Future
  • A Novel 111In-Labeled Anti-Prostate-Specific Membrane Antigen Nanobody for Targeted SPECT/CT Imaging of Prostate Cancer
  • Google Scholar

More in this TOC Section

  • How Sensitive Is the Upper Gastrointestinal Tract to 90Y Radioembolization? A Histologic and Dosimetric Analysis in a Porcine Model
  • 11C-Methionine PET of Myocardial Inflammation in a Rat Model of Experimental Autoimmune Myocarditis
  • Counting Rate Characteristics and Image Distortion in Preclinical PET Imaging During Radiopharmaceutical Therapy
Show more Basic Science Investigations

Similar Articles

Keywords

  • GRPR
  • bombesin
  • PET
  • 18F; prostate cancer
SNMMI

© 2025 SNMMI

Powered by HighWire